Role of tumor necrosis factor alpha in development of immunity against Cryptosporidium parvum infection

Infection and Immunity

Volumn 74, Issue 7, 2006, Pages 4379-4382

  Lean, I Sarah ^a   Lacroix Lamandé, Sonia ^b   Laurent, Fabrice ^b   McDonald, Vincent ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNITY; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; INTESTINE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL LINE; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DISEASE MODELS, ANIMAL; ENTEROCYTES; IMMUNITY, NATURAL; MICE; MICE, KNOCKOUT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745634141     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00195-06     Document Type: Article

References (23)

1. Brieland, J. K., C. Jackson, F. Menzel, D. Loebenberg, A. Cacciapuoti, J. Halpern, S. Hurst, T. Muchamuel, R. Debets, R. Kastelein, T. Churakova, J. Abrams, R. Hare, and A. O'Garra. 2001. Cytokine networking in lungs of immunocompromised mice in response to inhaled Aspergillus fumigans. Infect. Immun. 69:1554-1560.
2. Chen, X.-M., J. S. Keithly, C. V. Pava, and N. F. Larruso. 2002. Cryptosporidiosis. N. Engl. J. Med. 346:1723-1731.
3. Lacroix, S., R. Mancassola, M. Naciri, and F. Laurent. 2001. Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: role of tumor necrosis factor alpha in protection. Infect. Immun. 69:1635-1642.
4. Lean, I.-S., S. A. C. McDonald, M. Bajaj-Elliott, R. C. G. Pollok, M. J. G. Farthing, and V. McDonald. 2003. Interleukin-4 and transforming growth factor beta have opposing regulatory effects on gamma interferon-mediated inhibition of Cryptosporidium parvum reproduction. Infect. Immun. 71:4580-4585.
5. McDonald, S. A. C., J. E. O'Grady, M. Bajaj-Elliott, C. Notley, J. Alexander, F. Brombacher, and V. McDonald. 2004. Protection against early acute phase of Cryptosporidium parvum infection conferred by interleukin-4-induced expression of T helper 1 cytokines. J. Infect. Dis. 190:1019-1025.
6. McDonald, V., R. Smith, H. Robinson, and G. Bancroft. 2000. Host immune responses against Cryptosporidium. Contrib. Microbiol. 6:75-91.
7. Mizuki, M., A. Nakane, K. Sekikawa, Y. Tagawa, and Y. Iwakura. 2002. Comparison of host resistance to primary and secondary Listeria monocytogenes infections in mice by intranasal and intravenous routes. Infect. Immun. 70:4805-4811.
8. Morales, M. A. G., R. Mele, A. Ludovesi, F. Bruschi, F. Tosini, and E. Pozio. 2004. Cryptosporidium parvum-specific CD4 Th1 cells from sensitized donors responding to both fractionated and recombinant antigenic proteins. Infect. Immun. 72:1306-1310.
9. Murray, H. W., A. Jungbluth, E. Ritter, C. Montelibano, and M. W. Marino. 2000. Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment. Infect. Immun. 68:6289-6293.
10. Nussler, A., S. Pied, J. Goma, L. Renia, F. Miltgen, G. E. Grau, and D. Mazier. 1991. TNF inhibits malaria hepatic stages in vitro via synthesis of IL-6. Int. Immunol. 3:317-321.
11. Pollok, R. C. G., M. J. G. Farthing, M. Bajaj-Elliott, I. R. Sanderson, and V. McDonald. 2001. Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum. Gastroenterology 120:99-107.
12. Robinson, P., P. C. Okhuysen, C. L. Chappell, D. E. Lewis, I. Shahab, A. Janecki, and A. C. White, Jr. 2001. Expression of tumor necrosis factor alpha and interleukin 1β with Cryptosporidium parvum correlates with exposure but not symptoms. Infect. Immun. 69:1172-1173.
13. Schlüter, D., M. Deckert, H. Hof, and K. Frei. 2001. Toxoplasma gondii infection of neurons induces neuronal cytokine and chemokine production, but gamma interferon- and tumor necrosis factor-stimulated neurons fail to inhibit the invasion and growth of T. gondii. Infect. Immun. 69:7889-7893.
14. Schlüter, D., L.-Y. Kwok, S. Lütjen, S. Soltek, S. Hoffman, H. Kürner, and M. Deckert. 2003. Both lymphotoxin-α and TNF are crucial for control of Toxoplasma gondii in the central nervous system. J. Immunol. 170:6172-6182.
15. Seydel, K. B., T. Zhang, G. A. Champion, C. Fichtenbaum, P. E. Swanson, S. Tzipori, J. K. Griffiths, and S. L. Stanley, Jr. 1998. Cryptosporidium parvum infection of human intestinal xenografts in SCID mice induces production of human tumor necrosis factor alpha and interleukin-8. Infect. Immun. 66:2379-2382.
16. Shortman, K., and Y.-J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151-157.
17. Smith, L. M., M.-T. Bonafonte, and J. R. Mead. 2000. Cytokine expression and specific lymphocyte proliferation in two strains of Cryptosporidium parvum-infected γ-interferon knockout mice. J. Parasitol. 86:300-307.
18. Theodos, C. M. 1998. Innate and cell-mediated immune responses to Cryptosporidium parvum. Adv. Parasitol. 40:87-119.
19. Theodos, C. M., L. Povinelli, R. Molina, B. Sherry, and R. Titus. 1991. A role for tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo. Infect. Immun. 59:2839-2842.
20. Ungar, B. L. P., T. C. Kao, J. A. Burris, and F. D. Finkelman. 1991. Cryptosporidium infection in an adult mouse model. Independent roles for IFN-γ and CD4+ T lymphocytes in protective immunity. J. Immunol. 147:1014-1022.
21. Wilhelm, P., U. Ritter, S. Labbow, N. Donhauser, M. Röllinghoff, C. Bogdan, and H. Körner. 2001. Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J. Immunol. 166:4012-4019.
22. Wyatt, C. R., E. J. Brackett, L. E. Perryman, A. C. Rice-Ficht, W. C. Brown, and K. I. O'Rourke. 1997. Activation of intestinal intraepithelial T lymphocytes in calves infected with Cryptosporidium parvum. Infect. Immun. 65:185-190.
23. Zganiacz, A., M. Santosuosso, J. Wang, T. Yang, L. Chen, M. Anzulovic, S. Alexander, B. Gicquel, Y. Wan, J. Bramson, M. Inman, and Z. Xing. 2004. TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J. Clin. Investig. 113:401-413.